Advertisement

Topics

Rarecells® Company Profile

08:46 EDT 20th September 2018 | BioPortfolio

Rarecells® was founded in 2009 by Patrizia Paterlini-Brechot MD, PhD, Professor of Cell Biology and Oncology at University Paris Descartes Paris, France, to validate and commercialize the company’s patented ISET® method. Rarecells Diagnostics is located in Paris, France and is a wholly owned subsidiary of Rarecells Holding, located in New York.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

The main reason of cancer-related mortality is the spread of cancer cells to distant sites (micrometastases). However, only a few small groups of tumor cells can metastasize by acquiring m...

Companies [1 Associated Companies listed on BioPortfolio]

Rarecells®

Rarecells® was founded in 2009 by Patrizia Paterlini-Brechot MD, PhD, Professor of Cell Biology and Oncology at University Paris Descartes Paris, France, to validate and commer...

More Information about "Rarecells®" on BioPortfolio

We have published hundreds of Rarecells® news stories on BioPortfolio along with dozens of Rarecells® Clinical Trials and PubMed Articles about Rarecells® for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rarecells® Companies in our database. You can also find out about relevant Rarecells® Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record